TY  - JOUR
AU  - Piñar Morales, R
AU  - Ramírez Rivas, M A
AU  - Barrero Hernández, F J
PY  - 2021
DO  - 10.1016/j.nrl.2021.03.005
UR  - https://hdl.handle.net/10668/26031
T2  - Neurologia
AB  - The effect of SARS-CoV-2 infection in patients with multiple sclerosis (MS) and the influence of disease-modifying therapies (DMT) for MS on COVID-19 are unknown. To date, patients with MS have not been shown to present greater risk of COVID-19 or...
LA  - en
KW  - COVID-19
KW  - Disease-modifying therapy
KW  - Esclerosis múltiple
KW  - Linfopenia
KW  - Lymphocytopaenia
KW  - Multiple sclerosis
KW  - SARS-CoV-2
KW  - Seroprevalence
KW  - Seroprevalencia
KW  - Tratamiento modificador de la enfermedad
TI  - SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis.
T2  - Infección por SARS-CoV-2 y seroprevalencia en pacientes con esclerosis múltiple.
TY  - research article
VL  - 36
ER  -